Reaction
Soft Tissue Disorder reporting signals
As of the last recalculation, Soft Tissue Disorder appears in 1,104 FAERS reports alongside 28 co-occurring drug terms. The strongest observed disproportionality signal is TRIMETHOPRIM (PRR 181.6).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Trimethoprim | 103 | 181.6 | 183.2 |
| Ciclesonide | 105 | 160.5 | 161.8 |
| Anakinra | 106 | 133.2 | 134.0 |
| Desoximetasone | 85 | 91.0 | 91.4 |
| Diphenhydramine Hydrochloride Capsule, Liquid Filled | 43 | 39.4 | 39.5 |
| Hydromorphone Hydrochloride | 124 | 28.5 | 28.5 |
| Estradiol | 112 | 27.1 | 27.1 |
| Cortisone Acetate | 17 | 26.4 | 26.4 |
| Chlorhexidine Gluconate | 12 | 25.0 | 25.1 |
| Tocilizumab | 132 | 24.6 | 24.7 |
| Leflunomide | 113 | 22.6 | 22.6 |
| Cyclosporine | 108 | 20.2 | 20.2 |
| Hydroxychloroquine | 74 | 20.0 | 20.0 |
| Triamcinolone Acetonide Ointment Usp, 0.05% | 24 | 19.7 | 19.8 |
| Diphenhydramine Hydrochloride | 141 | 18.2 | 18.2 |
| Diphenhydramine | 57 | 17.9 | 17.9 |
| Quinine | 8 | 17.7 | 17.7 |
| Lorazepam | 144 | 17.2 | 17.2 |
| Abatacept | 110 | 16.5 | 16.5 |
| Ado-Trastuzumab Emtansine | 7 | 15.7 | 15.8 |
| Hydroxychloroquine Sulfate | 71 | 15.6 | 15.6 |
| Triamcinolone Acetonide | 24 | 14.9 | 15.0 |
| Lapatinib | 12 | 14.7 | 14.7 |
| Rituximab | 143 | 14.5 | 14.5 |
| Tofacitinib | 120 | 13.6 | 13.6 |
| Morphine Sulfate | 55 | 8.9 | 8.9 |
| Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride And Dextrose | 3 | 6.9 | 6.9 |
| Conjugated Estrogens And Medroxyprogesterone Acetate | 7 | 5.6 | 5.6 |